What Does an Oncology Pharmacy Technician Do?
Drug Topics
APRIL 20, 2023
From compounding to cleaning, oncology pharmacy technicians take on key responsibilities in infusion centers.
Thu.Apr 20, 2023
187 
Experts Discuss Harm Reduction and Substance Use Disorder Treatment
Pharmacy Times
APRIL 20, 2023
Host Christina Madison, PharmD, BCACP, AAHIVP, sat down with Jeffrey Bratberg, PharmD, FAPhA, a clinical professor in the college of pharmacy at the University of Rhode Island
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Xiromed intros generic Depo-Testosterone
Drug Store News
APRIL 20, 2023
Testosterone cypionate injection is indicated for replacement therapy in males with conditions associated with symptoms of deficiency or absence of endogenous testosterone.
FDA Approves Polatuzumab Vedotin-piiq Plus R-CHP For Certain Types of Diffuse Large B-cell Lymphoma
Pharmacy Times
APRIL 20, 2023
In a phase 3 trial, the risk of disease progression, relapse, or death was reduced by 27% with polatuzumab vedotin-piiq plus R-CHP compared with R-CHOP in adults with previously untreated diffuse large B-cell lymphoma or high-grade B-cell lymphoma.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
HIMSS23: Epic analytics leader details efforts to bring GPT-4 into healthcare and growing work in genomics, life sciences
Fierce Healthcare
APRIL 20, 2023
HIMSS23: Epic analytics leader details efforts to bring GPT-4 into healthcare and growing work in genomics, life sciences hlandi Thu, 04/20/2023 - 08:09
Evaluating Pharmacist Involvement in Sleep Disorder Management
Pharmacy Times
APRIL 20, 2023
Pharmacists are uniquely positioned to interact with patients who may be seeking an OTC drug or supplement as first-line therapy for short sleep duration.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
What Is Going On With Male Contraception?
Pharmacy Times
APRIL 20, 2023
Sixty years after the first hormonal birth control pill was marketed to women, men still have limited options with variable efficacy for birth control.
AI Potential in Health Care is Scary, But Awe-Inspiring
Drug Topics
APRIL 20, 2023
Health care leaders say AI could save countless lives, but there are difficult ethical questions that must be confronted.
Public Epitopes, Mechanisms of COVID-19 Reinfection Explained
Pharmacy Times
APRIL 20, 2023
Worldwide, the human immune system tends to make the same antibodies when targeting viruses, which can modify their structure to avoid detection.
'The Top Line': How Pfizer became the first in Big Pharma history to break $100B in sales, plus this week's headlines
Fierce Pharma
APRIL 20, 2023
'The Top Line': How Pfizer became the first in Big Pharma history to break $100B in sales, plus this week's headlines tcarey Thu, 04/20/2023 - 14:46
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Suspected suicide attempts surged among youth during pandemic, study shows
STAT
APRIL 20, 2023
The rate of suspected suicide attempts by self-poisoning among children and adults aged 10 to 19 in the U.S. rose by 30% in 2021 compared with pre-pandemic rates, according to a new study published Thursday. The largest surge was among the youngest in that age group — the rate rose 73% for 10- to 12-year-olds and about 49% for 13- to 15-year-olds, compared to 11% for 16- to 19-year-olds.
Letter 4: The Heart of a Manager
The Honest Apothecary
APRIL 20, 2023
My Dear Nephew Simon, So great to hear from you again. I’m glad that you found some of the practical advice in the last letter to be helpful. Don’t be too discouraged by the negative cultures being created by other managers in different departments. Focus on your team for now. In time we will talk about how you expand your influence with other stakeholders around the organization.
Pneumococcal Vaccine Candidate Shows Promise in Adults Aged 65 Years and Older
Pharmacy Times
APRIL 20, 2023
VAX-24 is designed to prevent invasive pneumococcal disease and pneumonia, which can be most serious for infants, young children, older adults, and those with immune deficiencies or some chronic health conditions.
Hasten Biopharmaceutic raises $315m for pipeline assets development
Pharmaceutical Technology
APRIL 20, 2023
Chinese firm Hasten Biopharmaceutic has raised $315m for business development of its pipeline assets in a financing round co-led by Singapore-based CBC Group and Abu Dhabi sovereign wealth fund Mubadala Investment, The funding round was supported by additional institutional investors. Hasten will also use the proceeds from the round to fund future acquisitions.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
GSK’s Gepotidacin Shows Potential as First-In-Class Drug for Uncomplicated UTIs
Pharmacy Times
APRIL 20, 2023
An Independent Data Monitoring Committee recommends stopping 2 phase 3 trials early for efficacy following positive results in November 2022.
Opinion: Judicial overreach is an immediate hazard to already precarious public health
STAT
APRIL 20, 2023
The United States is in poor health. Life expectancy rates have dropped precipitously , and racial health disparities continue, with white adults living more than five and a half years longer than Black adults on average. Child and teen mortality rates have also climbed, particularly among youth of color. Our maternal mortality rate is three times higher than those of other developed countries and is especially elevated for Black women.
Single dose psilocybin therapy improves major depression symptoms in cancer patients
Hospital Pharmacy Europe
APRIL 20, 2023
A single dose of psilocybin therapy improves symptoms of major depressive disorder in patients with different forms of cancer Major depressive disorder affects approximately 14.3% of patients with cancer. Advances in psycho-oncology show that psychotropic drugs are effective for cancer patients. Moreover, some data suggests that psilocybin therapy for cancer patients improves depressed mood and anxiety.
Forbion raises $1.47bn for two life sciences-focused funds
Pharmaceutical Technology
APRIL 20, 2023
European life sciences venture capital firm Forbion has raised €1.35bn ($1.47bn) across its two new funds. The latest fundraising brings the total funds managed by the company to €3bn ($3.28bn). The Forbion Ventures Fund VI and the Forbion Growth Opportunities Fund II both exceeded their original target sizes. The Forbion Ventures Fund VI’s final close reached the hard cap of €750m ($821.76m), while the Forbion Growth Opportunities Fund II secured €600m ($657.41m).
FMI report: Fewer shoppers cutting back on items purchased, despite higher prices
Drug Store News
APRIL 20, 2023
Shoppers concerned about rising prices continue to look for deals to stretch dollars as weekly grocery spending increases, according to FMI’s U.S. Grocery Shopper Trends survey report.
Bempedoic acid use for statin-intolerant patients reduces incidence of MACE
Hospital Pharmacy Europe
APRIL 20, 2023
Use of bempedoic acid among statin-intolerant patients reduces the incidence of major adverse cardiovascular events compared to placebo Bempedoic acid (BA) modulates both ATP-citrate lyase and AMP-activated protein kinase activity thereby reducing LDL cholesterol. In addition, bempedoic acid is an alternative LDL lowering agent for statin-intolerant patients.
Rite Aid posts Q4, full-year results
Drug Store News
APRIL 20, 2023
Rite Aid’s retail pharmacy segment revenues increased 8.2% over the prior year quarter driven by an extra week in the fourth quarter and an increase in prescriptions.
FDA approves first new B-cell lymphoma treatment in 20 years
European Pharmaceutical Review
APRIL 20, 2023
It has been nearly 20 years since a new treatment option has become available [for] newly diagnosed with diffuse large B-cell lymphoma [in the US]” The US Food and Drug Administration (FDA) has approved Polivy ® (polatuzumab vedotin-piiq) in combination with Rituxan ® (rituximab), cyclophosphamide, doxorubicin and prednisone (R-CHP). “It has been nearly 20 years since a new treatment option has become available to people newly diagnosed with diffuse large B-cell lymphoma,” shared Dr Levi G
Chamberlain Coffee launches RTD plant-based cold brew lattes
Drug Store News
APRIL 20, 2023
Through an exclusive collaboration with Walmart, the beverages will be available in four flavors—mocha latte, cinnamon bun latte, vanilla latte and traditional cold brew latte.
Pharma á la carte 04/20/23
The Honest Apothecary
APRIL 20, 2023
A gathering of some interesting Pharma and healthcare related news from around the web for Thursday, April 20, 2023 : What Health Systems Could Learn from Starbucks “ Sara Vaezy: Companies like Starbucks and Amazon have done really well at connecting buyers and sellers. In our case, it’s connecting the clinician and the patient, or the system to the consumer with things such as content, information, tools and services.” Reminds of the classic book by Fred Lee, If Disney Ran You
Biden to tap head of National Cancer Institute to lead NIH
STAT
APRIL 20, 2023
President Biden will nominate oncologist Monica Bertagnolli, director of the National Cancer Institute, to lead the National Institutes of Health, three people familiar with the White House’s plans told STAT. Bertagnolli last fall became the first woman to direct NCI, the largest of the NIH’s 27 departments, amid the president’s efforts to relaunch the Cancer Moonshot with the goal of halving cancer deaths and vastly curbing new cases.
Targovax announces plans to rebrand as Circio
Pharmaceutical Technology
APRIL 20, 2023
Targovax has unveiled plans to rebrand as Circio , reflecting its strategic shift to focus on expediting the development of its innovative circular RNA (circRNA) platform. Initially reported in 2011, CircRNA is a naturally occurring class of RNA. CircRNA is resistant to the main cellular RNA degradation mechanisms and therefore has a prolonged half-life compared to linear mRNA.
Supreme Court Decision on Mifepristone to Come Friday
Drug Topics
APRIL 20, 2023
This comes after a district court in Texas ruled to keep Mifepristone available, but with heavy restrictions.
'Compelling results from Karyopharm study using combination of drugs to treat myelofibrosis
Outsourcing Pharma
APRIL 20, 2023
Symptom improvements have been hailed as âvery compellingâ after results from a phase 1 study into a combination of drugs to treat myelofibrosis prove positive.
Benefits, Concerns With OTC Vitamins and Supplements
Pharmacy Times
APRIL 20, 2023
It is vital to consult with a health care provider before taking OTC vitamins and supplements.
Epic and Microsoft’s AI collaboration, Amazon and 3M, & Abbott’s CGM momentum
STAT
APRIL 20, 2023
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
Can probiotics help treat diabetes?
The Checkup by Singlecare
APRIL 20, 2023
As the interest in natural alternatives continues to rise, many patients may be considering probiotics for potential health benefits. Patients with diabetes, in particular, may be curious about whether they can take probiotics and how probiotics may affect their blood sugar levels. As it turns out, research has shown several potential benefits of probiotics for diabetes.
Hutchmed 's rare gastric cancer drug accepted for review in China
Outsourcing Pharma
APRIL 20, 2023
A drug to treat a rare cancer that grows where the esophagus and stomach join has been accepted for review by the China National Medical Products Administration (NMPA).
Excedrin unveils Head Care line of dietary supplements, nutrient mixes
Drug Store News
APRIL 20, 2023
As part of the launch, Excedrin debuted Head Care Club, which features exclusive routines from Emmy Award-winning choreographer Derek Hough to help support everyday head health.
Opinion: Generative AI’s three possibly insurmountable challenges for health care
STAT
APRIL 20, 2023
Talk about AI in medicine often focuses on the most exiting possible innovations like precision diagnostics, clinical prediction systems, and analytics-driven drug discovery. However, with the arrival of large language models like GPT-4, Bard, and LLaMA, there is growing enthusiasm for how AI might reshape the more mundane aspects of clinical practice: clinical documentation and electronic health records.
Let's personalize your content